Identifying distributors in a supply chain that may have ushered phony Avastin into the U.S. has stepped up interest in a broader investigation of foreign-drug imports, The Wall Street Journal says. Report
Identifying distributors in a supply chain that may have ushered phony Avastin into the U.S. has stepped up interest in a broader investigation of foreign-drug imports, The Wall Street Journal says. Report